{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:23:21Z","timestamp":1790429001716,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","revespcardiol.org","clinicalkey.com","clinicalkey.com.au","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.rec.2015.12.033","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T08:50:20Z","timestamp":1461315020000},"page":"672-680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Microparticle Shedding by Erythrocytes, Monocytes and Vascular Smooth Muscular Cells Is Reduced by Aspirin in Diabetic Patients"],"prefix":"10.1016","volume":"69","author":[{"given":"Gemma","family":"Chiva-Blanch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Suades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Padr\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Vilahur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ybarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Pou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Badimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2015.12.033_bib0175","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/CIRCULATIONAHA.106.658948","article-title":"Increasing cardiovascular disease burden due to diabetes mellitus: The Framingham Heart Study","volume":"115","author":"Fox","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2015.12.033_bib0180","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2015.12.033_bib0185","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIR.0b013e3181e3b133","volume":"121","author":"Pignone","year":"2010","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2015.12.033_bib0190","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","article-title":"Aspirin as an antiplatelet drug","volume":"330","author":"Patrono","year":"1994","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2015.12.033_bib0195","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.108.768283","article-title":"Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk","volume":"118","author":"Eikelboom","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2015.12.033_bib0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1007174723608","article-title":"Blood polymorphonuclear leukocyte activation in atherosclerosis: effects of aspirin","volume":"25","author":"Egger","year":"2001","journal-title":"Inflammation."},{"key":"10.1016\/j.rec.2015.12.033_bib0205","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1538-7836.2004.00936.x","article-title":"Measuring circulating cell-derived microparticles","volume":"2","author":"Jy","year":"2004","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.rec.2015.12.033_bib0210","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.101.8.841","article-title":"Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes","volume":"101","author":"Mallat","year":"2000","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2015.12.033_bib0215","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1160\/TH12-07-0486","article-title":"Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques","volume":"108","author":"Suades","year":"2012","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.rec.2015.12.033_bib0220","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.ATV.0000252064.97632.2c","article-title":"Circulating platelet-derived microparticles are associated with atherothrombotic events: a marker for vulnerable blood","volume":"27","author":"Namba","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.rec.2015.12.033_bib0225","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/eurheartj\/ehq478","article-title":"Circulating CD31 +\/Annexin V+ microparticles correlate with cardiovascular outcomes","volume":"32","author":"Sinning","year":"2010","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2015.12.033_bib0230","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/01.CIR.0000036596.59665.C6","article-title":"Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus","volume":"106","author":"Diamant","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2015.12.033_bib0235","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2005.02.047","article-title":"Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease","volume":"45","author":"Koga","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2015.12.033_bib0240","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2006.10.053","article-title":"Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques","volume":"49","author":"Leroyer","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2015.12.033_bib0245","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/blood.V95.3.930.003k46_930_935","article-title":"Cellular origin and procoagulant properties of microparticles in meningococcal sepsis","volume":"95","author":"Nieuwland","year":"2000","journal-title":"Blood."},{"key":"10.1016\/j.rec.2015.12.033_bib0250","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/aps.2013.188","article-title":"Microvesicles and diabetic complications-novel mediators, potential biomarkers and therapeutic targets","volume":"35","author":"Wang","year":"2014","journal-title":"Acta Pharmacol Sin."},{"key":"10.1016\/j.rec.2015.12.033_bib0255","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.2337\/diabetes.51.9.2840","article-title":"Type 1 and type 2 diabetic patients display different patterns of cellular microparticles","volume":"51","author":"Sabatier","year":"2002","journal-title":"Diabetes."},{"key":"10.1016\/j.rec.2015.12.033_bib0260","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/09537100903114545","article-title":"Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus","volume":"20","author":"Nomura","year":"2009","journal-title":"Platelets."},{"key":"10.1016\/j.rec.2015.12.033_bib0265","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.atherosclerosis.2009.06.037","article-title":"Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus","volume":"208","author":"Feng","year":"2010","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.rec.2015.12.033_bib0270","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11239-013-1000-2","article-title":"Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status","volume":"37","author":"Zhang","year":"2014","journal-title":"J Thromb Thrombolysis."},{"key":"10.1016\/j.rec.2015.12.033_bib0275","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s00125-001-0772-7","article-title":"Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus","volume":"45","author":"Omoto","year":"2002","journal-title":"Diabetologia."},{"key":"10.1016\/j.rec.2015.12.033_bib0280","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"SAFEHEART Investigators. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2015.12.033_bib0285","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1160\/TH13-07-0612","article-title":"Circulating CD45+\/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients","volume":"111","author":"Suades","year":"2014","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.rec.2015.12.033_bib0290","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.rec.2015.12.033_bib0295","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ."},{"key":"10.1016\/j.rec.2015.12.033_bib0300","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"Belch","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.rec.2015.12.033_bib0305","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/heart.85.3.265","article-title":"Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials","volume":"85","author":"Sanmuganathan","year":"2001","journal-title":"Heart."},{"key":"10.1016\/j.rec.2015.12.033_bib0310","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","article-title":"Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial","volume":"300","author":"Ogawa","year":"2008","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2015.12.033_bib0315","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MBC.0000000000000199","article-title":"Effect of acetylsalicylic acid on platelet activation and oxidative profile in a set of Brazilian patients with type 2 diabetes mellitus","volume":"26","author":"Duarte","year":"2015","journal-title":"Blood Coagul Fibrinolysis."},{"key":"10.1016\/j.rec.2015.12.033_bib0320","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2362.2010.02299.x","article-title":"Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans","volume":"40","author":"Lubsczyk","year":"2010","journal-title":"Eur J Clin Invest."},{"key":"10.1016\/j.rec.2015.12.033_bib0325","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1590\/1414-431X20143628","article-title":"Effects of simvastatin\/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy","volume":"47","author":"Camargo","year":"2014","journal-title":"Braz J Med Biol Res."},{"key":"10.1016\/j.rec.2015.12.033_bib0330","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1046\/j.1538-7836.2003.00456.x","article-title":"Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner","volume":"1","author":"Bir\u00f3","year":"2003","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.rec.2015.12.033_bib0335","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/CIRCRESAHA.110.233403","article-title":"Leukocyte-derived microparticles in vascular homeostasis","volume":"110","author":"Angelillo-Scherrer","year":"2012","journal-title":"Circ Res."},{"key":"10.1016\/j.rec.2015.12.033_bib0340","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1161\/01.ATV.0000249639.36915.04","article-title":"Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects","volume":"26","author":"Chironi","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S188558571630007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S188558571630007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:20:45Z","timestamp":1600474845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S188558571630007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S188558571630007X"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2015.12.033","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microparticle Shedding by Erythrocytes, Monocytes and Vascular Smooth Muscular Cells Is Reduced by Aspirin in Diabetic Patients","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2015.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2015.12.034","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}